Update to the contraindications listings for products containing povidone-iodine
Members are advised to review and update their clinical procedures accordingly.
07.10.2024 - This article has been updated since it was first published. We are happy to clarify the use of povidone iodine as we accept that the previous version of this article caused uncertainty amongst some of our members. We apologise for any inconvenience caused.
Members are advised to review and update their clinical procedures accordingly.
The Royal College of Podiatry (RCPod) is sign-posting its members to the British National Formulary (BNF) which has updated the listing for povidone-iodine products.
Previously these carried ‘caution’ information. This has now been updated to carry ‘contraindications’ information when using products containing an active ingredient of povidone-iodine.
All members in clinical practice are reminded to regularly check the BNF for up-to-date changes in relation to any dressings or medicaments used.
The BNF is now available online here.
Members should update themselves on the specific contraindications and risk for each povidone-iodine containing product that they utilise within practise.
Members should be assured that povidone iodine is safe to use provided the contraindications listed in BNF are complied with.
To view the updated entries for povidone-iodine, please visit the BNF entry online here and the separate listing for iodine-based dressings here.